PHARMExcel welcomes new MHRA Corporate Plan 2023-2026
PHARMExcel welcomes new risk-proportionate regulations and priority regulatory pathways in MHRA Corporate Plan 2023-2026
PHARMExcel welcomes new risk-proportionate regulations and priority regulatory pathways in MHRA Corporate Plan 2023-2026
Learn how collaboration is key to accelerating research to clinical trial stage and other key insights from the UK CRFN conference
PHARMExcel joins forces with the BIA.
We’re proud of our vital vaccine trial work, leading the way in prevention and control of infectious diseases
PHARMExcel CRO awarded ISO 9001:2015 quality management standard by the International Standards Organisation.
We are delighted to announce the appointment of Russell Wheatcroft as Chief Operating Officer of PHARMExcel